Congressman Ami Bera, M.D. and Congressman Scott Peters (CA-52) are leading a group of 28 members of Congress to urge the Food and Drug Administration (FDA) to take steps to reduce the sky-rocketing costs of generic prescription drugs.
BREAK IN TRANSCRIPT
"Americans should be able to access quality, affordable prescription medication," Congressman Bera said. "Competition is critical to maintaining reasonable pricing and the backlog in generic drug applications, as well as the unintended consequences of the Unapproved Drugs Initiative, has created opportunities for some irresponsible drug companies to make a lot of money while Americans suffer. This is not acceptable. We urge the FDA to take these common sense steps to help increase competition and lower drug costs."